Reaction Biology Selected for Participation in National Chemical Biology Consortium to Support Drug Discovery Utilizing Surface Plasmon Resonance ("SPR") Technology
/PRNewswire/ -- Reaction Biology Corporation ("Reaction"), an industry-leading provider of drug discovery services, today announced that it has been selected...
Baden Wüberg Lindsay Rocco Rebecca Eells Leidos Biomedical Research Inc Experimental Therapeutics Next Program National Cancer Institute
Source: prnewswire.com